Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes

References

• Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3–11.
   PubMed Web of Science ®Google Scholar
• Sripadam R, Stratford J, Henry AM, Jackson A, Moore CJ, Price P. Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study. Radiother Oncol 2009;90:312–7.
   PubMed Web of Science ®Google Scholar
• Perez CA, Michalski JM, Purdy JA, Wasserman TH, Williams K, Lockett MA. Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: Preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 2000;47:629–37.
   PubMed Web of Science ®Google Scholar
• Gulliford SL, Foo K, Morgan RC, Aird EG, Bidmead AM, Critchley H, . Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: Evidence from MRC RT01 trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys 2010;76:747–54.
   PubMed Web of Science ®Google Scholar
• Jackson A, Skwarchuk MW, Zelefsky MJ, Cowen DM, Venkatraman ES, Levegrun S, . Late rectal bleeding after conformal radiotherapy of prostate cancer (II): Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001;49:685–98.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76(Suppl 3):123–9.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Valdagni R, Rancati T, Sanguineti G. Dose-volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol 2009;93:153–67.
   PubMed Web of Science ®Google Scholar
• Muren LP, Ekerold R, Kvinnsland Y, Karlsdottir A, Dahl O. On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. Radiother Oncol 2004;70:11–9.
   PubMed Web of Science ®Google Scholar
• Muren LP, Karlsdottir A, Kvinnsland Y, Wentzel-Larsen T, Dahl O. Testing the new ICRU 62 ‘Planning Organ at Risk Volume’ concept for the rectum. Radiother Oncol 2005;75: 293–302.
   PubMed Web of Science ®Google Scholar
• McKenzie A, van Herk M, Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol 2002;62:299–307.
   PubMed Web of Science ®Google Scholar
• ICRU Report 62. Prescribing, recording and reporting photon beam radiotherapy (supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, Bethesda, MD; 1999.
   Google Scholar
• Karlsdottir A, Johanesson DC, Muren LP, Wentzel-Larsen T, Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004;71:43–53.
   PubMed Web of Science ®Google Scholar
• Hermanek P, Hutter RVP, Sobin LH, Spiessi B, Wagner G. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Berlin and Heidelberg: Springer-Verlag; 1997.
   Google Scholar
• Mellinger GT, Gleason D, Bailar J. The histology and prognosis of prostatic cancer. J Urol 1967;97:331–7.
   PubMed Web of Science ®Google Scholar
• ICRU Report 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements. Bethesda, MD; 1993.
   Google Scholar
• Karlsdóttir A, Muren LP, Wenzel-Larsen T, Dahl O. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys 2008;70:1478–86.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;5:1341–6.
   Web of Science ®Google Scholar
• Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, . Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:1151–61.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Mayr NA, Yuh WT. Behind EUD. Acta Oncol 2008; 47:971–2.
   PubMed Web of Science ®Google Scholar
• Mohan R, Mageras GS, Baldwin B, Brewster LJ, Kutcher GJ, Leibel S, . Clinically relevant optimization of 3-D conformal treatments. Med Phys 1992;19:933–44.
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123–35.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Lee AK, . Fit of a normal-tissue complication probability (NTCP) model to Grade ≥ 2 late rectal toxicity data from patients treated on protocol RTOG 94-06 [Abstract]. Int J Radiat Oncol Biol Phys 2007;69(Suppl 3):8–9.
   Web of Science ®Google Scholar
• Rancati T, Fiorino C, Gagliardi G, Cattaneo GM, Sanguineti G, Borca VC, . Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 2004;73:21–32.
   PubMed Web of Science ®Google Scholar
• Skwarchuk MW, Jackson A, Zelefsky MJ, Venkatraman ES, Cowen DM, Levegrün S, . Late rectal toxicity after conformal radiotherapy of prostate cancer I: Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000; 47:103–13.
   PubMed Web of Science ®Google Scholar
• Gulliford SL, Partridge M, Sydes MR, Andreyev J, Dearnaley DP. A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity. Radiother Oncol 2010;94:241–7.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Honoré H, Høyer M, von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 2005;74:203–10.
   PubMed Web of Science ®Google Scholar
• Muren LP, Wasbo E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, . Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences. Int J Radiat Oncol Biol Phys 2008;71:1034–41.
   PubMed Web of Science ®Google Scholar
• Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829–35.
   PubMed Web of Science ®Google Scholar
• Yan D, Jaffray DA, Wong JW. A model to accumulate fractionated dose in a deforming organ. Int J Radiat Oncol Biol Phys 1999;44:665–75.
   PubMed Web of Science ®Google Scholar
• Sanguineti G, Somani M, Eugene E, Little M, Chen G, Berilgen J, . Dosimetric predictors of diarrhea during radiotherapy for prostate cancer [Abstract]. Int J Radiat Oncol Biol Phys 2007;69(Suppl 3):346–7.
   Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, Sydes MR, Dearnaley DP, Partridge M. Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: An analysis of data from the MRC RT01 trial (ISRCTN 47772397). Phys Med Biol 2009;54:6535–48.
   PubMed Web of Science ®Google Scholar
• Grau C, Muren LP, Høyer M, Lindegaard J, Overgaard J. Image-guided adaptive radiotherapy-integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182–5.
   PubMed Web of Science ®Google Scholar
• Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol 2009;48: 238–44.
   PubMed Web of Science ®Google Scholar
• Webb S. The contribution, history, impact and future of physics in medicine. Acta Oncol 2009;48:169–77.
   PubMed Web of Science ®Google Scholar
• Jeraj R. Future of physics in medicine and biology. Acta Oncol 2009;48:178–84.
   PubMed Web of Science ®Google Scholar
• Van Herk M. Will IGRT live up to its promise? Acta Oncol 2008;47:1186–7
   PubMed Web of Science ®Google Scholar